Edison, NJ, United States of America

Bosco D'Sa

USPTO Granted Patents = 4 


Average Co-Inventor Count = 6.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2004-2010

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Bosco D'Sa: A Spotlight on His Contributions to Pharmaceutical Chemistry

Introduction

Bosco D'Sa is an accomplished inventor based in Edison, NJ, with a total of four patents to his name. His work primarily focuses on advancements in pharmaceutical chemistry, showcasing his dedication to enhancing drug formulations and their efficacy. D'Sa's innovative contributions have significant implications for the medical field, particularly in designing compounds that help combat various diseases.

Latest Patents

Among Bosco D'Sa's latest patents, two stand out for their groundbreaking approaches to synthesis and preparation in pharmaceutical chemistry. The first patent, titled **"Synthesis of CCR5 receptor antagonists"**, outlines a novel method for synthesizing a complex compound related to CCR5 receptor antagonists. This invention emphasizes the synthesis of 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine], along with its intermediates from readily available starting materials. The innovative route described in this patent presents potential new avenues for therapeutic drug development.

The second patent, **"Preparation of pharmaceutical salts of piperazine compounds"**, details a process designed to directly generate pharmaceutically acceptable salts that are enriched with specific rotameric configurations of basic compounds. By strategically choosing an acid and a solvent medium, this inventive approach allows for the preparation of desired rotamers of pharmaceutically useful salts, enhancing the effectiveness of drug formulations.

Career Highlights

Bosco D'Sa has made significant strides in his career by working at the Schering Corporation, where he collaborates with other leading experts in the field. His work often intersects with crucial phases of drug development, where precision and innovation are critical to success. D'Sa's patents reflect his commitment to providing the pharmaceutical industry with advanced solutions that target various health concerns.

Collaborations

Throughout his career, D'Sa has had the privilege of collaborating with esteemed colleagues such as William W. Leong and Minzhang Chen. Their joint efforts in research and development have fostered a creative environment for innovation within the company, enabling them to tackle complex challenges in pharmaceutical chemistry head-on.

Conclusion

Bosco D'Sa exemplifies the spirit of innovation within the pharmaceutical industry. His contributions, particularly in the synthesis of chemical compounds and the preparation of pharmaceutical salts, pave the way for advancements that could significantly impact drug efficacy and patient care. As he continues to work in collaboration with talented peers at Schering Corporation, the potential for future innovations remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…